Literature DB >> 10231649

Persistent hypertension after removal of adrenal tumours.

P Sapienza1, A Cavallaro.   

Abstract

OBJECTIVE: To assess the long-term results of operation for adrenal hypertension and to evaluate reasons and potential risk factors for the persistence or recurrence of hypertension.
DESIGN: Retrospective clinical study.
SETTING: Teaching hospital, Italy.
SUBJECTS: 48 patients with benign adrenal tumours who were preoperatively hypertensive and treated by adrenalectomy between 1980 and 1996. MAIN OUTCOME MEASURES: Factors that influenced the persistence of hypertension after removal of the adrenal tumours.
RESULTS: During a mean (SD) follow-up of 77 (12) months, 4 (8.3%) patients developed cardiovascular or cerebrovascular complications. 24 patients had had a history of hypertension for less than 5 years and the remaining 24 for 5 years or more. Blood pressure returned to the normal range after operation in 22 patients (46%). 14 patients (29%) had persistent hypertension that required treatment with antihypertensive drugs, but 12 required less intensive treatment than before adrenalectomy. Multivariate analysis showed that age at presentation was the only significant factor predictive of persistent hypertension (p < 0.05); sex, haematochemical tests, raised preoperative blood pressure, duration of hypertension preoperatively, and size of tumour were not.
CONCLUSION: The success in reversing hypertension after adrenalectomy for benign tumour is strongly related to age at presentation.

Entities:  

Mesh:

Year:  1999        PMID: 10231649     DOI: 10.1080/110241599750007027

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  8 in total

1.  Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas.

Authors:  Yah Yuen Tan; Jennifer B Ogilvie; Frederick Triponez; Nadine R Caron; Electron K Kebebew; Orlo H Clark; Quan-Yang Duh
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

2.  Long-term follow-up after adrenalectomy for primary aldosteronism.

Authors:  Andreas Meyer; Georg Brabant; Matthias Behrend
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

Review 3.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

Review 4.  Treatment of primary aldosteronism: Where are we now?

Authors:  Asterios Karagiannis
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

5.  Surgically correctable adrenal-dependent hypertension: a report of five cases.

Authors:  F Ofei; R Darko; J Appiah-Kusi; H Aduful; H Baddoo; Y Adu-Gyamfi; Y Tettey; Rk Gyasi; L Aleksenko; Ed Yeboah; Eq Arc-Hampong; Aa Yeboah; E Ogoe
Journal:  Ghana Med J       Date:  2007-06

6.  Rare normalization of blood pressure after unilateral adrenalectomy in 31 patients with Conn syndrome.

Authors:  Jacek Ziaja; Jerzy Chudek; Robert Król; Jacek Pawlicki; Andrzej Wiecek; Lech Cierpka
Journal:  Langenbecks Arch Surg       Date:  2007-01-26       Impact factor: 2.895

7.  Gene Expression Profile of Persistent Postoperative Hypertension Patients with Aldosterone-producing Adenomas.

Authors:  Li-Fang Xie; Jin-Zhi Ouyang; An-Ping Wang; Wen-Bo Wang; Xin-Tao Li; Bao-Jun Wang; Yi-Ming Mu
Journal:  Chin Med J (Engl)       Date:  2015-06-20       Impact factor: 2.628

8.  Changes in blood pressure, blood sugar, and quality of life in patients undergoing pheochromocytoma surgery: a prospective cohort study.

Authors:  Pradeep Prakash; Rashmi Ramachandran; Nikhil Tandon; Rajeev Kumar
Journal:  Indian J Urol       Date:  2019 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.